{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:51:01Z","timestamp":1793641861516,"version":"4.5.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ygyno.2023.02.009","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T01:33:59Z","timestamp":1677288839000},"page":"95-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes"],"prefix":"10.1016","volume":"171","author":[{"given":"Angiolo","family":"Gadducci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Multinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Antonio","family":"De Vitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Cosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvestro","family":"Carinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Damiano","family":"Aletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2023.02.009_bb0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2559.2009.03231.x","article-title":"Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients","volume":"54","author":"Abeler","year":"2009","journal-title":"Histopathology."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2012.01.021","article-title":"Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases","volume":"72","author":"Koivisto-Korander","year":"2012","journal-title":"Maturitas."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0015","series-title":"Female Genital Tumours. WHO Classification of Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2020"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAP.0000000000000046","article-title":"Endometrial stromal tumors: the new WHO classification","volume":"21","author":"Conklin","year":"2014","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pathol.2017.11.086","article-title":"Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations","volume":"50","author":"Hoang","year":"2018","journal-title":"Pathology."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2559.1981.tb01761.x","article-title":"Mesenchymal tumours of the uterus. VII. A clinicopathological study of 60 endometrial stromal nodules","volume":"5","author":"Tavassoli","year":"1981","journal-title":"Histopathology."},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2023.02.009_bb0035","first-page":"S105","article-title":"Uterine sarcomas","volume":"131","author":"Prat","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0040","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1055\/a-0882-4116","article-title":"Sarcoma of the uterus. Guideline of the DGGG and OEGGG (S2k level, AWMF register number 015\/074, February 2019)","volume":"79","author":"Denschlag","year":"2019","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/gyno.1996.0314","article-title":"Endometrial stromal sarcoma: analysis of treatment failures and survival","volume":"63","author":"Gadducci","year":"1996","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0050","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/clinpract11040103","article-title":"New aspects of sarcomas of uterine Corpus-a brief narrative review","volume":"11","author":"Kostov","year":"2021","journal-title":"Clin. Pract."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0055","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/IGC.0000000000000281","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus","volume":"24","author":"Pautier","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0060","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.bjc.6604527","article-title":"Endometrial stromal sarcoma: a population-based analysis","volume":"99","author":"Chan","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.critrevonc.2017.12.009","article-title":"Systemic treatment in adult uterine sarcomas","volume":"122","author":"Desar","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0070","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/ijgc-2022-003383","article-title":"Primary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma","volume":"32","author":"Smith","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0075","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2147\/CMAR.S187849","article-title":"High-grade endometrial stromal sarcoma: a retrospective study of factors influencing prognosis","volume":"11","author":"Zhang","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijgo.2013.01.025","article-title":"Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy","volume":"122","author":"Malouf","year":"2013","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2012.06.030","article-title":"High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes","volume":"127","author":"Tanner","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2007.06.011","article-title":"The management of patients with uterine sarcoma: a debated clinical challenge","volume":"65","author":"Gadducci","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40644-019-0247-z","article-title":"Utility of diffusion-weighted and contrast-enhanced magnetic resonance imaging in diagnosing and differentiating between high- and low-grade uterine endometrial stromal sarcoma","volume":"19","author":"Huang","year":"2019","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0100","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/IGC.0000000000001114","article-title":"Endometrial stromal sarcoma of the uterus: magnetic resonance imaging findings including apparent diffusion coefficient value and its correlation with Ki-67 expression","volume":"27","author":"Li","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.14366\/usg.15045","article-title":"Ultrasonographic findings of low-grade endometrial stromal sarcoma of the uterus with a focus on cystic degeneration","volume":"35","author":"Park","year":"2016","journal-title":"Ultrasonography."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13000-019-0897-y","article-title":"JAZF1-SUZ12 endometrial stromal sarcoma forming subserosal masses with extraordinary uptake of fluorodeoxyglucose on positron emission tomography: a case report","volume":"14","author":"Fujiishi","year":"2019","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0115","doi-asserted-by":"crossref","first-page":"22581","DOI":"10.18632\/oncotarget.15127","article-title":"18F-FDG\/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma","volume":"8","author":"Yamamoto","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2967\/jnumed.112.113472","article-title":"18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis","volume":"54","author":"Zhao","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0125","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00000478-199005000-00002","article-title":"Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases","volume":"14","author":"Chang","year":"1990","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0130","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/1933719118778801","article-title":"Adjuvant hormonal therapy for low-grade endometrial stromal sarcoma","volume":"26","author":"Deshmukh","year":"2019","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00428-018-2358-5","article-title":"Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma","volume":"473","author":"Park","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0140","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1054\/bjoc.1999.1038","article-title":"Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas","volume":"82","author":"Reich","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0145","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PGP.0000000000000353","article-title":"Androgen receptor expression in endometrial stromal sarcoma: correlation with Clinicopathologic features","volume":"36","author":"Roy","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00428-019-02588-8","article-title":"Low-grade endometrial stromal sarcoma with a novel MEAF6-SUZ12 fusion","volume":"475","author":"Makise","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gore.2017.03.002","article-title":"A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1","volume":"20","author":"Allen","year":"2017","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0160","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/PAS.0b013e318272c612","article-title":"Endometrial stromal sarcomas with sex cord differentiation are associated with PHF1 rearrangement","volume":"37","author":"D\u2019Angelo","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1631\/jzus.B2000797","article-title":"LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies","volume":"22","author":"Li","year":"2021","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0170","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/gcc.22485","article-title":"Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma","volume":"56","author":"Micci","year":"2017","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1158\/0008-5472.CAN-05-2485","article-title":"Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1\/PHF1 and EPC1\/PHF1 in endometrial stromal sarcoma","volume":"66","author":"Micci","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0180","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/modpathol.2017.42","article-title":"BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology","volume":"30","author":"Chiang","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0185","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/modpathol.2017.162","article-title":"ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity","volume":"31","author":"Lewis","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0190","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/sj.bjc.6603986","article-title":"Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma","volume":"97","author":"Amant","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0195","doi-asserted-by":"crossref","first-page":"iv51","DOI":"10.1093\/annonc\/mdy096","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejca.2020.08.016","article-title":"Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa\u2019 italiana di Ginecologia E Ostetricia)","volume":"139","author":"Ferrandina","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0205","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000494225","article-title":"Low-grade endometrial stromal sarcoma - a review","volume":"41","author":"Thiel","year":"2018","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0210","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/ijgc-2018-000063","article-title":"Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis","volume":"29","author":"Nasioudis","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0215","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ygyno.2020.04.001","article-title":"Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysis","volume":"157","author":"Nasioudis","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2010.12.363","article-title":"Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma","volume":"121","author":"Dos Santos","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2017.05.036","article-title":"Low-grade and high-grade endometrial stromal sarcoma: a National Cancer Database study","volume":"146","author":"Seagle","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0230","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/jog.14198","article-title":"Long-term impact of lymphadenectomies in patients with low-grade, early-stage uterine endometrial stroma sarcoma","volume":"46","author":"Zhang","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0235","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ygyno.2013.12.032","article-title":"Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases","volume":"132","author":"Bai","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0240","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jog.12506","article-title":"Fatal case of multiple recurrences of endometrial stromal sarcoma after fertility-sparing management","volume":"41","author":"Morimoto","year":"2015","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0245","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.18632\/oncotarget.12491","article-title":"Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0250","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.21037\/atm-20-2180","article-title":"Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series, a population-based analysis and review of the literature","volume":"8","author":"Zheng","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0255","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.3892\/ol.2016.5186","article-title":"Letrozole as second-line hormonal treatment for recurrent low-grade endometrial stromal sarcoma: a case report and review of the literature","volume":"12","author":"Nakamura","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0260","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijsu.2015.09.072","article-title":"Influence of different treatment modalities on survival of patients with low-grade endometrial stromal sarcoma: a retrospective cohort study","volume":"23","author":"Zhou","year":"2015","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0265","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejca.2008.01.019","article-title":"Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer group study (protocol 55874)","volume":"44","author":"Reed","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0270","series-title":"Uterine Neoplasms (Version 1.2022)","author":"National Comprehensive Cancer Network","year":"2021"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0275","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13569-015-0024-0","article-title":"Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden Hospital","volume":"5","author":"Thanopoulou","year":"2015","journal-title":"Clin. Sarcoma Res."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0280","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/ijgc-2018-000064","article-title":"Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French sarcoma group","volume":"29","author":"Meurer","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0285","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s12094-020-02512-6","article-title":"Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma","volume":"23","author":"Cabrera","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0290","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0295","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2017.03.021","article-title":"YWHAE-rearranged high-grade endometrial stromal sarcoma: two-center case series and response to chemotherapy","volume":"145","author":"Hemming","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0300","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00428-018-2470-6","article-title":"Recent advances in the histological and molecular classification of endometrial stromal neoplasms","volume":"473","author":"Ferreira","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0305","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/243298","article-title":"Potential therapeutic targets in uterine sarcomas","volume":"2015","author":"Cuppens","year":"2015","journal-title":"Sarcoma."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0310","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ygyno.2006.01.024","article-title":"A case of c-kit positive high-grade stromal endometrial sarcoma responding to Imatinib Mesylate","volume":"101","author":"Salvatierra","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0315","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2013.199","article-title":"Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement","volume":"27","author":"Lee","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0320","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejca.2021.04.034","article-title":"Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: a systematic review and meta-analysis","volume":"152","author":"Saerens","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0325","first-page":"2","article-title":"Macrophage infiltration and genetic landscape of undifferentiated uterine sarcomas","author":"Przybyl","year":"2017","journal-title":"JCI Insight."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0330","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2010.04.008","article-title":"Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?","volume":"118","author":"Garg","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0335","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2559.2011.04115.x","article-title":"Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma","volume":"62","author":"Feng","year":"2013","journal-title":"Histopathology."},{"key":"10.1016\/j.ygyno.2023.02.009_bb0340","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/ijgc-2020-001409","article-title":"Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a surveillance epidemiology, and end results database analysis","volume":"30","author":"Wu","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0345","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/gcc.22649","article-title":"Novel EPC1 gene fusions in endometrial stromal sarcoma","volume":"57","author":"Dickson","year":"2018","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.ygyno.2023.02.009_bb0350","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/his.14008","article-title":"Uterine mesenchymal tumours: recent advances","volume":"76","author":"Momeni-Boroujeni","year":"2020","journal-title":"Histopathology."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823000781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823000781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:51:46Z","timestamp":1715820706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823000781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":70,"alternative-id":["S0090825823000781"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.02.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}